Want to join the conversation?
$BIIB 2Q15 Call: Global TECFIDERA revenue increased 26% YoverY; revenues consisted of $721MM in US and $163MM outside US. Ex-US TECFIDERA sales decreased 8% vs. 1Q15. Interferon revenues, including AVONEX and PLEGRIDY were $690MM, including $455MM in US and $235MM in sales outside US. TYSABRI revenue was $463MM; $269MM in US and $195MM ex-US.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.